Free Cash Flow Build Up

ChemoCentryx Inc (CCXI)

$ 10.74
-0.23 (-2.10%)
Year
A/P
2013
Actual
2014
Projected
2015
Projected
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 6.06------------
EBITDA -38.54------------
EBIT -39.11------------
Tax Rate 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIAT -39.11------------
Depreciation 0.58------------
Accounts Receivable -------------
Inventories -------------
Accounts Payable -------------
Capital Expenditure -0.55-0.35-0.22-0.30-0.72-0.84-0.79-15.41-----
UFCF -39.09------------
WACC
PV UFCF ------------
SUM PV UFCF -